Cargando…

Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related events

BACKGROUND: This study analyzes the impact of skeletal-related events (SRE) on healthcare resource utilization (HCRU) and costs incurred by patients with bone metastases (BM) from solid tumors (ST), who are therapy-naïve to bone targeting agents (BTAs). METHODS: German claims data from 01/01/2010 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hardtstock, Fränce, Kocaata, Zeki, Wilke, Thomas, Dittmar, Axel, Ghiani, Marco, Belozeroff, Vasily, Harrison, David J., Maywald, Ulf, Tesch, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881971/ https://www.ncbi.nlm.nih.gov/pubmed/33459901 http://dx.doi.org/10.1007/s10198-020-01247-z

Ejemplares similares

Preferences of Patients with Chronic Hepatitis B – A Discrete Choice Experiment on the Acceptability of Functional Cure
por: Hardtstock, Fraence, et al.
Publicado: (2020)

Identifying the Causes Increasing the Risk of Non-Adherence in Adult Patients with Asthma: An Analysis Combining Patient Survey Data with German Claims Data
por: Müller, Sabrina, et al.
Publicado: (2021)

Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
por: Hardtstock, Fränce, et al.
Publicado: (2020)

Evaluating the Economic Burden of Relapses in Neuromyelitis Optica Spectrum Disorder: A Real-World Analysis Using German Claims Data
por: Knapp, Rachel K., et al.
Publicado: (2021)

EPH35 Post-COVID Conditions in Hospitalized COVID-19 Patients in Germany
por: Pacis, S, et al.
Publicado: (2022)

POSA32 Early COVID-19 Pandemic in Germany: Patient Characteristics and Clinical Outcomes
por: Pacis, S, et al.
Publicado: (2022)

P64 Evaluating the Impact of the COVID-19 Pandemic on Mortality after Myocardial Infarctions Hospitalization in Germany
por: Krieger, J, et al.
Publicado: (2022)

P21 Social Distancing and Trends in Influenza Hospitalization during the COVID-19 Outbreak: A Difference-in-Difference Analysis of German Claims Data
por: Pacis, S, et al.
Publicado: (2022)

Epidemiology and treatment of patients with Chronic rhinosinusitis with nasal polyps in Germany—A claims data study
por: Starry, Alexandra, et al.
Publicado: (2022)

Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis
por: Kocaata, Zeki, et al.
Publicado: (2022)

Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors
por: Brown-Glaberman, Ursa, et al.
Publicado: (2012)

Use of Biologic Therapies in the Treatment of Asthma – A Comparative Real World Data Analysis on Healthcare Resource Utilization and Costs Before and After Therapy Initiation
por: Hardtstock, Fraence, et al.
Publicado: (2022)

Data Resource Profile: The Multiple Sclerosis Documentation System 3D and AOK PLUS Linked Database (MSDS-AOK PLUS)
por: Ghiani, Marco, et al.
Publicado: (2023)

Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours
por: Durán, I., et al.
Publicado: (2013)

Enhanced Bone Metastases in Skeletally Immature Mice
por: Haley, Henry R., et al.
Publicado: (2018)

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
por: Polascik, Thomas J
Publicado: (2009)

Indicators of active disease and steroid dependency in patients with inflammatory bowel diseases not treated with biologics in a German real-world-setting
por: Bokemeyer, B., et al.
Publicado: (2020)

Skeletal morbidity rates over time in patients with bone metastases from solid tumors reported in bone modifying agents randomised trials
por: Poon, Michael, et al.
Publicado: (2012)

Lenvatininb as Treatment for Naïve Patients with Aggressive Thyroid Cancer Bone Metastases and Bad Performance Status
por: Garcia-Rodriguez, Sonia, et al.
Publicado: (2020)

Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study
por: Chiroli, Silvia, et al.
Publicado: (2012)

Dexamethasone Coanalgesic Administration in Steroid Naïve and Steroid Non-Naïve Patients for the Prevention of Pain Flares after Palliative Radiotherapy for Bone Metastases
por: Tonev, Dimitar G., et al.
Publicado: (2022)

Prognostic value of the bone scan index using a computer-aided diagnosis system for bone scans in hormone-naive prostate cancer patients with bone metastases
por: Miyoshi, Yasuhide, et al.
Publicado: (2016)

EE391 Impact of the COVID-19 Pandemic on the Healthcare Resource Use of People With Newly Diagnosed Mood/Affective Disorder
por: Junker, S, et al.
Publicado: (2022)

Bone metastases and skeletal-related events from neuroendocrine tumors
por: Van Loon, Katherine, et al.
Publicado: (2015)

Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases
por: Park, Sun H., et al.
Publicado: (2018)

Exploiting machine learning for predicting skeletal-related events in cancer patients with bone metastases
por: Wang, Zhiyu, et al.
Publicado: (2016)

Validating the screening criteria for bone metastases in treatment-naïve unfavorable intermediate and high-risk prostate cancer - the prevalence and location of bone- and lymph node metastases
por: Rud, Erik, et al.
Publicado: (2022)

Skeletal-Related Events After Surgery With or Without Radiotherapy for Bone Metastases to Weight-Bearing Bones
por: Lanier, Claire M, et al.
Publicado: (2022)

The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy
por: Nicolini, A, et al.
Publicado: (1999)

Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases
por: von Moos, Roger, et al.
Publicado: (2015)

High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases
por: Laganà, Marta, et al.
Publicado: (2020)

Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With Osimertinib
por: Brouns, Anita J.W. M., et al.
Publicado: (2023)

Health state utilities for skeletal-related events secondary to bone metastases
por: Matza, Louis S., et al.
Publicado: (2013)

CO1 Mapping The Landscape Of Covid-19 Clinical Trials In The US: Assessing The Opportunities And Gaps In Trial Designs, Interventions And Endpoints
por: Kocaata, Z., et al.
Publicado: (2020)

Healthcare use and costs before and after parathyroidectomy in patients on dialysis
por: Belozeroff, Vasily, et al.
Publicado: (2013)

P40 REAL-WORLD TREATMENT PATTERNS OF PATIENTS INITIATING THIRD-LINE THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA IN EUROPE
por: Lehne, M., et al.
Publicado: (2023)

Importance of antiresorptive therapies for patients with bone metastases from solid tumors
por: Talreja, Draupadi B
Publicado: (2012)

Management of pain in patients with bone metastases
por: Jing, Doudou, et al.
Publicado: (2023)

Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States
por: Hernandez, Rohini K, et al.
Publicado: (2015)

Impact of Extraskeletal Metastases on Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer with Bone Metastases
por: Lobo-Martins, Soraia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ord4aorr4ojhj4gd5c6pr6gbl7